4
The access of BMAA to the adult rodent brain appears to be restricted by the large neutral amino acid transporter in the blood brain barrier (BBB) (Smith et al., 1992) . Our previous studies in mice have confirmed poor transfer of BMAA to the adult brain and low, homogeneous distribution in various brain regions (Karlsson et al., 2009) . However, the characteristics of the developing BBB differ from those of the adult; the developing BBB can permit xenobiotics to enter the brain (Adinolfi, 1985; Banos et al., 1978) . The permeability of the neonatal BBB to BMAA and the extent of transfer of this neurotoxin to the neonatal brain is not currently known, nor has the transplacental transfer of BMAA to the fetal brain been investigated. The first aim of this study was therefore to investigate the uptake and distribution of BMAA in the fetal and neonatal mouse brain using autoradiography.
The brain growth spurt (BGS) is an important stage in the development of the central nervous system (CNS)
. The timing of this stage differs among species. In humans, it starts during the last trimester of pregnancy and continues until at least 2 years after birth, and the corresponding period in rodents is the first 3-4 weeks after birth (Dobbing and Sands, 1979) . The BGS is characterized by rapid neurodevelopmental changes such as axonal and dendritic growth, establishment of neuronal connections, synaptogenesis, and proliferation of glia cells followed by myelination (Davison and Dobbing, 1968) . The BGS is a sensitive period with respect to exposure to various xenobiotics (Eriksson, 1997; Viberg et al., 2003) . However, little is known about the effects of BMAA during the BGS. A previous study focusing on neurochemical effects following neonatal exposure to BMAA reported changes that appeared to be related to modification of neuronal development rather than to a direct excitotoxic action (Dawson et al., 1998) . The second aim of this study was therefore to investigate the effects of BMAA on the development of behavioral characteristics during the BGS in neonatal and juvenile rats. 6 sections (20 µm) were mounted on X-ray film (Hyperfilm-3 H; Amersham Biosciences, UK) and exposed at -20ºC for 7 months.
For the neonatal brain distribution experiment during the peak of the BGS, three 10-day-old C57Bl/6J male mouse pups were given a sc injection of 3 H-BMAA (7.3 µg/kg; 4 mCi/kg). The pups were sacrificed 1 hour, 3 hours or 24 hours after the injection by exposure to gaseous CO 2 and processed as described above.
Effects of BMAA exposure during the brain growth spurt in rats
An outline of the experiment is illustrated in Figure 1 . The litters were cross-fostered on the day of birth [postnatal day (PND) 0] in order to spread the genetic material. Each litter contained 8 pups,
with a homogeneous distribution of males and females as far as possible. Two litters were assigned to the control and low dose group respectively, and 3 litters to the high dose group. The male Wistar rat pups were given one daily sc injection (20 µl/g) of BMAA 200 mg/kg (n=8) or 600 mg/kg (n=11) dissolved in HBSS, or vehicle (n=8), for 2 days during the peak of the BGS (PND 9 and 10).
Upon handling of the litters for testing or treatment, the dam was always first removed from the home cage and then the pups. The whole litter was placed close together in a macrolon cage containing wood chip bedding material and body temperature was maintained with a heating pad.
The litter was always returned to the home cage before the dam. The litter weights were monitored on PND 1, 4, 7, 9, 10-16, 19 and 22; all pups were weaned on PND 22. After weaning, the female rats were excluded from the experiment and the male rats were housed in standard macrolon cages in their respective treatment groups. The tests were performed during the light phase of the light/dark cycle and all animals were tested in an alternative order. All arenas and apparatus used in the behavioral studies were wiped clean with 10 % ethanol and allowed to dry between the trials. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 The nestfinding test
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The nestfinding test investigates olfactory discrimination and locomotor development (Meyerson, 1985; Sigling et al., 1996) . An arena (42×26×18 cm) was divided into two equal compartments with a nest at both ends, 15 cm from the center. One of the nests was made of wood chip bedding from the home cage and the other nest was made of fresh wood chip bedding material. Each pup was placed in the center facing 90º from the nests and allowed to find their home nest over a period of 90 seconds. The test was repeated three times, each trial with a starting point 180º from the previous. To be scored as a positive response, the pups needed to find their home nest in at least two consecutive trials. The animals were tested on PND 6-8 for determination of a baseline response and on PND 12 after the BMAA treatment.
The modified open field test
Early locomotor ability and activity of the rat pups was tested on PND 13 using a size adjusted open field (OF) test (42×26×18 cm), with absorbent paper covering the bottom of the arena. The test was conducted in dimmed light and the sessions lasted for 5 min. The total durations immobile or moving, and the number of abnormal movements (i.e. falling when rearing and during forward locomotion) were scored.
The inclined plane test
Muscle performance was tested in an inclined plane test, described in detail elsewhere (Rivlin and Tator, 1977; Roos et al., 2003) , on PND 16. The maximum angle at which the rat could maintain itself on the plane was recorded. The test was repeated three times and the average angle was used as a dependent variable. Page 7 of 38  Toxicological Sciences   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 The audiogenic immobility reaction (freezing) is a passive defensive mechanism that first appears around PND 16 in rats and reaches is developmental peak around 3 weeks of age (Hansen and Hard, 1980; Hard et al., 1982) . The animals were tested on PND 19 in a cage placed in a soundisolated box with an attached horn. The rats were allowed to adapt to the environment for 5 min before the freezing reaction was triggered with a 5 second noise. The time immobile (time to the first distinct movement) and the number of animals immobile for the total test time (10 min) were scored.
The audiogenic immobility test

The elevated plus maze test
The elevated plus maze (EPM) test has been widely used to investigate anxiety-like behavior (Lister, 1990) . The maze used in this experiment has been described elsewhere (Roman et al., 2007) . The rat was placed in the center of the EPM facing an open arm and was tested under dimmed light for 10 min on PND 24-25. All animals were tested once.
The open field test
The OF test is a commonly used test for measuring general exploration, ambulation and emotional reactivity. The arena used in this study was as described elsewhere (Roman et al., 2007) with the exception that no start box was used. The test was conducted for 15 min under dimmed light, on PND 26-27, to ensure locomotor ability, since the emotional component is more pronounced under bright light (Lister, 1990 ). All animals were tested once.
Behavioral recordings
The animals were monitored by a TV-video set-up. Behavioral parameters were scored manually using the software Score 3.3 (Pär Nyström, Copyright Soldis, Uppsala, Sweden); a visit to one of the defined zones was scored when both hind legs had crossed over into that section. For the EPM and OF tests, the time before visiting a zone (latency; LAT; s), number of visits (frequency; FRQ), duration of the visits (DUR; s), number of grooming and rearing, and percentage of animals visiting a zone or performing a behavior (% OCC) were registered. The total number of visits to the defined zones (TOTACT) was used as a measure of locomotor activity. The total number of stretchedattend postures (TOTSAP) and head dipps (TOTDIP) were also scored in the EPM test. The Ethovision system (version 2.3, Noldus Information Technology, Wageningen, The Netherlands) was used for recording the distance moved in the OF test (TOTDISTANCE; locomotor activity).
Statistical analysis
The body weights of the animals, which showed a normal distribution, were analyzed using ANOVA and Fisher's PLSD as post hoc test. The non-parametric Kruskal-Wallis test followed by the Mann-Whitney U-test was used for inter-group comparisons of behavioral parameters. When animals did not enter a zone, the values were considered as missing, except for the comparison of percentage duration of visits to each zone. The Chi-square test was used for analysis of %OCC. The distance moved in the OF arena was analyzed over three 5-min periods using the non-parametric Friedman two-way analysis of variance test and the Wilcoxon signed rank test. Differences were considered statistically significant at p < 0.05. The StatView 5.0.1 (SAS Institute Inc., Cary, NC) and Statistica 8.0 (StatSoft Inc., Tulsa, OK) software were used for the statistical analyses.
Results
Tissue distribution of 3 H-BMAA in fetal and neonatal mice
The autoradiographic study demonstrated transplacental transfer of 3 H-BMAA after a single iv injection to pregnant mice on day 14 of gestation. The results revealed a distinct BBB in the dams; the level in maternal brain was lower than the level in blood at the 30 min survival interval. In contrast, the level of radioactivity in the fetal tissues was higher than that in the maternal blood at 30 min and increased gradually at the later survival intervals. The distribution in fetal tissues was homogeneous at 30 min except for slightly higher radioactivity in the eyes. At 3 h, there was high, selective uptake by the fetal CNS and the level was even higher at the longest survival interval of 24 h ( Figure 2 ).
The autoradiographic study also revealed an increase in radioactivity in the neonatal brain and spinal cord from 30 min to 24 hours after a single sc injection of 3 H-BMAA in 10-day-old mice.
The general level of radioactivity in the neonatal brain was lower than the level in blood at the 30 min survival interval. Selective uptake was, however, demonstrated in the striatum and hippocampus at all survival intervals studied (30 min, 3 h, 24 h). The radioactivity was present in the CA1, CA2, CA3 and dentate gyrus regions of the hippocampus. In addition, there was selective uptake in the brain ventricles, choroid plexus, and the pituitary gland at 30 min and 3 h. Twentyfour hours after the injection, radioactivity was selectively located in the thalamus, cerebellum, brain stem, and spinal cord, as well as the striatum and hippocampus ( Figure 3 ).
The general tissue distribution pattern of 3 H-BMAA in other tissues of the dams and 10-day-old pups was similar to that in previously reported studies of adult male mice (Karlsson et al., 2009 ).
Effects of BMAA exposure during the brain growth spurt in rats General findings
All rat pups were closely monitored for seizure activity immediately after the injections. The high dose of BMAA (600 mg/kg) induced delayed motor convulsions with loss of righting reflex in two animals. The pups showed emprosthotonic-like seizures with the neck, spine and limbs curled in a flexed ball-like position (Mares and Velisek, 1992) . These pups, along with two other pups that lost the righting reflex, were sacrificed for ethical reasons and to avoid confounding effects. No weight loss was observed in the BMAA-treated rats. There was, however, a small, transient effect on body weight gain in the group receiving 600 mg/kg which resulted in a significant difference in body weight on PND 10-16. No significant difference in body weight was observed on PND 19 and 22. No changes in developmental landmarks such as eye opening were seen (data not shown).
The nestfinding test
During the developmental process, the nest-finding ability of the control pups improved significantly from baseline to PND 12, at which point all control pups located the home nest and fulfilled the criteria for a positive response. In contrast, the nest-finding ability of the BMAAtreated pups did not improve significantly from baseline to PND 12. Eighty-eight percent of the pups in the low dose group and 71 % of the pups in the high dose group fulfilled the criteria for a positive response in the test (Figure 4 ). There were no significant differences between the treatment groups on PND 12. A general observation was that the BMAA-exposed pups appeared to be hyperactive, and pups in the high dose group demonstrated abnormal movements such as unsteady gait and falling on their backs.
The modified open field test
The locomotor test on PND 13 revealed that BMAA had a dose-dependent effect on locomotor activity and ability. The BMAA-treated rat pups were hyperactive, and were mobile for significantly longer than the control pups ( Figure 5 ). All the pups in the high dose group demonstrated abnormalities in locomotor ability, revealed as unsteady gait with occasional overbalancing, i.e. falling when rearing and during forward locomotion ( Figure 5 ). One animal in the control group landed in a strange position once after rearing but did not show the disturbance seen in the pups receiving the high dose of BMAA. The inclined plane test
Muscle performance tested on an inclined plane on PND 16 did not differ between the treatment groups ( Figure 6 ).
The audiogenic immobility test
The audiogenic immobility reaction tested on PND 19 demonstrated reduced freezing in BMAAtreated rats. Eighty-eight percent of the animals in the control group remained immobile for the entire testing period (10 min), compared with 63 % and 29 % of the groups receiving the low and high doses of BMAA, respectively. The duration of the freezing response was significantly shorter in the pups receiving BMAA at 600 mg/kg than in the controls ( Figure 7 ).
The elevated plus maze test
The results of the 10-min EPM trial on PND 24-25 are given in Supplementary material (Table 1 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 general locomotor activity, and rearing, a measure of exploratory activity, did not differ between the groups.
The open field test
The results from the 15-min OF test on PND 26-27 are shown in Supplementary material (Table 2 ).
An overall comparison revealed a significant difference between groups for total time spent in the outer circle (H=11.85, p<0.01) as well as total time spent in the center (H=11.06, p<0.01) and duration per visit to the center (H=10.77, p<0.01). Groupwise comparison showed that the duration of visits to the outer circle was significantly longer in both the low and high dose BMAA groups compared with controls (both p<0.01), indicating higher levels of thigmotaxis. The total time in the center (p<0.01 and p<0.05) and the time per visit in the center (p<0.01 and p<0.05) were also significantly shorter in both respective BMAA dose groups compared with the controls. Only 57 % of the animals in the high dose group visited the center. There were no significant differences in locomotor ability and total activity (i.e. TOTACT and TOTDISTANCE) between the groups in the OF test. The animals in the high dose group did not, however, habituate to the environment in a manner similar to that of control rats and animals exposed to BMAA at 200 mg/kg. The total distance moved in the arena by control animals and rats in the low dose group progressively and significantly decreased over the three 5-min time periods of the trial. This sign of habituation was not noted in the rats exposed to BMAA at 600 mg/kg. Thus, for the rats in the high dose group, there were no significant differences in activity levels between the first 5 min and the last 5 min periods (Figure 8 ). An overall comparison of the difference in distance moved between the first and the last 5 min periods revealed a significant difference between the groups (H=6.79, p<0.05). The difference in distance moved was significantly smaller in the high dose group compared to the low dose group and controls, respectively (both p<0.05). 
Discussion
This study demonstrated placental transfer of the cyanobacterial neurotoxin BMAA, with pronounced uptake by the fetal mouse brain as well as transfer across the BBB to the neonatal brain and distinct localization in brain areas such as the hippocampus and striatum. These findings are in contrast to our previous results on the transfer of BMAA to the brain in adult mice, where we found poor BBB transfer and no specific localization in discrete brain regions (Karlsson et al., 2009 ).
BMAA appears to be transported by the large neutral amino acid transporter in the adult BBB (Smith et al., 1992) . However, the characteristics of the developing BBB differ from those of the adult in that some amino acids need to move through more easily so as to meet the demands of the rapidly growing brain (al-Sarraf et al., 1995; Banos et al., 1978) . The marked uptake of 3 H-BMAA in the developing brain may thus be related to facilitated transport through the BBB.
Our investigation also revealed that BMAA exposure during the BGS induced significant changes in the neurodevelopment of neonatal rats. For example, BMAA induced acute behavioral deficits, such as impaired locomotor ability and hyperactivity, in neonatal animals. Notably, these effects were no longer detectable in juvenile rats, i.e. on PND 24-27, suggesting a recovery. However, the BMAA-treated animals continued to display behavioral characteristics that differed significantly from controls at this age, including alterations that could suggest cognitive impairment.
BMAA is a neurotoxic amino acid that can affect neurite outgrowth and neurofilament protein levels in cultured cells (Abdulla and Campbell, 1993) . It is known to activate ionotropic as well as metabotropic glutamate receptors and to induce neuronal degeneration via an excitotoxic mechanism (Copani et al., 1991; Lobner et al., 2007; Rao et al., 2006) . Activation of glutamate receptors could induce several changes in the neurodevelopment as the glutamatergic system is involved in the modulation of many events occurring during the BGS (Ruediger and Bolz, 2007) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 The glutamate receptors and their subunits are differentially regulated during development, with distinct regional and temporal expression profiles, and often with transient peak levels during the BGS (Catania et al., 1994; D'Souza et al., 1993; Kornhuber et al., 1988; McDonald and Johnston, 1990 ). For instance, glutamate binding sites in hippocampus peaks at PND 9 and gradually decreases to adult values at PND 23 in rats (McDonald and Johnston, 1990) . In accordance most of the NMDA receptor subunits are highly expressed in the hippocampus and peaks in the same period (Monyer et al., 1994) . Our autoradiographic study revealed distinct uptake and binding of The acute effects observed in a few rat pups following exposure to BMAA during the peak of the BGS, i.e. PND 9-10, confirmed that the BGS is a sensitive period for glutamatergic compounds (Ikonomidou et al., 1989; McDonald et al., 1988) . The hyperflexion (emprosthotonic) seizures observed in two of the animals in the high dose group (600 mg/kg) are a unique type of seizure that appears to be induced exclusively by NMDA receptor agonists in rodents no older than 25 days (Kabova et al., 1999; Mares and Velisek, 1992) . Older mice receiving high doses of BMAA icv has been shown to develop a transient hyperexcitable state followed by a delayed whole-body shake/wobble phase which could be selectively inhibited by pretreatment with a NMDA receptor antagonist (Ross and Spencer, 1987) . However, the observed seizures in rat pups treated with BMAA (600 mg/kg) on PND 9-10 do not appear to be similar to the described effects in older animals. The present results are in contrast with a previous report, in which BMAA treatment on PND 2 and 5 (500 mg/kg) induced no seizures or major motor system impairment (Dawson et al., (Schmidt et al., 1992) . Local injections of glutamate agonists into the striatum have been shown to enhance locomotor activity (Donzanti and Uretsky, 1984; Svensson et al., 1994) . Thus, the acute hyperactivity observed in pups could have been caused by BMAA stimulation of the glutamatergic system.
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The audiogenic immobility reaction, tested on PND 19, demonstrated a reduced freezing reaction in the high dose group. The reduced freezing response was not caused by lower muscle strength, since there were no differences between the groups in the inclined plane test performed on PND 16. The monoaminergic systems and brain areas such as the amygdala and the periaqueductal gray are thought to be involved in the control of the audiogenic freezing response but the neurobiological mechanisms are largely unknown (Chen et al., 2006; Hard et al., 1982) . The shorter freezing response observed in the pups treated with BMAA at 600 mg/kg could have been caused by the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 higher locomotor activity observed in this group of animals.
After weaning, the animals were further tested in the EPM and OF tests. Running the OF test under dimmed light conditions monitors general locomotor ability and activity (Lister, 1990) . The acute BMAA-induced effects on locomotor activity were no longer detectable by PND 24-27, suggesting that the animals had recovered over a short period of time. Recovery could have been due to a transient stimulation of glutamate receptors, which would not have induced any permanent changes, or to greater plasticity in the affected areas.
The autoradiographic study demonstrated distinct uptake of 3 H-BMAA in the hippocampus of neonatal mice. This brain area is important for cognitive function and appears necessary for reduction in the response to an environment over time, i.e. habituation (Giovannini et al., 2001; Vianna et al., 2000; Vinogradova et al., 1993) . Habituation is considered to be a simple form of learning. For rats, it is generally demonstrated within 10 min in an OF test and can be used as a non-specific test of ontogeny of learning (Ehman and Moser, 2006) . The OF test revealed that the BMAA-treated rats in the high dose group did not habituate to the environment the way the control rats did, which could indicate disturbed cognitive function. This observation is supported by the report of Dawson et al. (1998) , who demonstrated higher activity in neonatal rats exposed to BMAA than in controls when retesting in the OF test, a result which appeared to depend on failure to habituate. However, further studies are needed in order to fully evaluate the effects of BMAA on cognitive processes.
The glutamatergic system is believed to play a major part in the pathogenesis of anxiety, and metabotropic glutamate receptor agonists have been shown to reduce anxiety-like behavior in rodents (Bergink et al., 2004) . In the EPM test, the rats that received the high dose had a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 significantly longer total duration and duration per visit in the open arms than the other two groups.
Elevated open arm activity is generally considered to be a characteristic of low anxiety-like behavior (Hogg, 1996; Lister, 1990 ) but has also been suggested to be indicative of flight response (Holmes et al., 2000) . The results from the OF test revealed significantly more thigmotaxis in both groups of BMAA-exposed rats. Thigmotaxis has been suggested to be a useful parameter for anxiety-like behavior in rodents (Treit and Fundytus, 1988) , which could suggest a contrasting result to that of the EPM test. However, the original interpretation of behavior in the OF test was that an animal displaying high anxiety-like behavior would demonstrate low ambulation and high defecation (Hall, 1934) , and these parameters did not differ between the groups in our OF test. To our knowledge, no studies on the effects of BMAA on anxiety-like behavior have been reported but seem warranted.
The extent of human exposure to this cyanobacterial neurotoxin is not known. One study that measured BMAA levels in the bats from Guam mentioned earlier estimated that human consumption of one animal could correspond to ingestion of >3 g BMAA (Banack and Cox, 2003) .
However, the evidence for the presence of BMAA in human brain tissue is equivocal (Montine et al., 2005; Murch et al., 2004) . Most cyanobacteria produce BMAA, and the toxin has been detected in several water systems (Cox et al., 2005; Esterhuizen and Downing, 2008; Metcalf et al., 2008) .
Further, BMAA, like other cyanobacterial toxins, could accumulate in aquatic food chains (Falconer et al., 1992; Zimba et al., 2001 ).
In conclusion, the results presented in this study demonstrate pronounced transfer of BMAA to fetal and neonatal rodent brains. BMAA induced significant changes in neonatal rat behavioral neurodevelopment including alterations that suggest possible cognitive impairment. Increased knowledge of the long-term effects on cognitive function following fetal and neonatal exposure to 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 risk to children's health. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 olfaction in unconditioned fear in developing rats. J Neurosci 26, 233-40. Codd, G. A., Metcalf, J. S., and Beattie, K. A. (1999) . Retention of Microcystis aeruginosa and microcystin by salad lettuce (Lactuca sativa) after spray irrigation with water containing cyanobacteria. Toxicon 37, 1181-5.
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Figure 4
The nestfinding test on PND 12 demonstrated that all rats in the control group fulfilled the criterion for a positive response. In contrast to control rats the performance of neonatal rats receiving BMAA 200 or 600 mg/kg (on PND 9 and 10) did not significantly improve versus baseline. There were no significant differences between the treatment groups at baseline or on PND 12. Bars represent the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 percentage of animals with a positive response. ** p< 0.01 compared with baseline (Chi-Square test).
Control n=8; BMAA 200 mg/kg n=8; 600 mg/kg n=7. 
Figure 6
The inclined plane test on PND16 demonstrated no effects on muscle performance in rats exposed to BMAA 200 or 600 mg/kg neonatally (on PND 9 and 10) compared with vehicle-treated controls.
The maximum angle at which the rat could maintain itself on a plane was recorded. Bars represent means ± SEM of three trials. Control n=8; BMAA 200 mg/kg n=8; 600 mg/kg n=7. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60
Figure 8
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